YPSN Ypsomed Holding AG

522.83USD440.60 CHF · SWX+0.50%Mkt Cap: 6.87B USDP/E: 34.94

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…

Institutional holders10 on file

Key Statistics

Company
Market Cap6.87B USD
Enterprise Value7.23B USD
Revenue (TTM)813.86M USD
Gross Profit373.32M USD
Net Income (TTM)263.34M USD
Revenue/Share60.91 USD
Last Price522.83 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990
Valuation
P/E (Trailing)34.94
P/E (Forward)28.98
PEG3.81
EV/EBITDA21.43
EV/Revenue8.89
P/S8.45
P/B7.74
EPS (TTM)14.96 USD
EPS (Forward)18.04 USD
52W Range
309.1296% of range531.37
52W High531.37 USD
52W Low309.12 USD
Profitability
Gross Margin43.04%
Oper. Margin31.01%
EBITDA Margin41.47%
Profit Margin30.36%
ROE29.66%
ROA16.48%
ROIC23.12%
ROCE23.52%
Growth
Revenue Growth-12.40%
Earnings Growth-36.20%
Cash Flow & Leverage
Operating CF364.01M USD
CapEx (TTM)383.40M USD
FCF Margin-22.33%
FCF Yield-2.64%
Net Debt356.15M USD
Net Debt/EBITDA1.06
Net Debt/FCF—
Balance Sheet
Debt/Equity0.35
Current Ratio0.94
Quick Ratio0.69
Book Value/Sh67.53 USD
Cash/Share3.35 USD
Dividends
Fwd Div Rate5.22 USD
Trail. Div Rate5.22 USD
Div. Yield1.00%
5Y Avg Yield0.50%
Payout Ratio34.89%
Ex-Div DateJul 3, 2026
Pay DateJul 3, 2024
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)501.43 USD
Upside (mean)-4.1%
Target Range332.26 USD – 619.42 USD
332.26-4.1% to mean619.42
# Analysts14
Ownership
Shares Out.13.15M
Float3.51M
Insiders69.59%
Institutions15.91%
Technical
SMA 50449.87 (+16.2%)
SMA 200408.79 (+27.9%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)16.05K
Avg Vol (10d)24.53K
Technical Indicators
RSI (14)71.6
MACD15.0603
MACD Signal11.7483
MACD Hist.+3.3121
BB Upper527.55 USD
BB Middle482.42 USD
BB Lower437.30 USD
BB Width18.71%
ATR (14)13.07 USD
Vol Ratio (20d)1.16x

About Ypsomed Holding (SWX: YPSN)

›

Ypsomed Holding (SWX: YPSN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 2,025 employees.

The shares were at 440.60 CHF on 19 November 2026, up 36.0% over 52 weeks. Its 52-week range is 260.50 CHF to 447.80 CHF: the price is 1.6% below the high and 69.1% above the low.

At a market capitalisation of 5.79B CHF, it trades at 34.9 times trailing earnings and 29.0 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 29% for YPSN. It pays a dividend yielding 1.00% (it pays out 35% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Ypsomed Holding reports return on equity of 29.7%, an operating margin of 31.0% and revenue down 12.4% year over year.

Its debt exceeds its cash by 300.14M CHF, a debt-to-equity ratio of 0.35. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 422.57 CHF is 4.1% below the current price. The next earnings report is expected on 19 May 2027.